Study identifies the nuclear protein Pin1 as pivotal in the regulation of senescence, offering new avenues for senotherapeutic development.
The process of cellular senescence, a state of permanent cell cycle arrest, is a key area of longevity research due to the part it plays in both aging and cancer prevention. As cells age or encounter oncogenic stimuli, they cease dividing, thereby preventing the proliferation of potentially tumorigenic cells. However, senescence is a double-edged sword, and senescent cells, and their toxic emissions, have been associated with a wide range of age-related conditions, such as diabetes, osteoporosis, cardiovascular disease, stroke, Alzheimer’s and other dementias, cancer and osteoarthritis. Additionally, senescence has been linked to deteriorations in vision, mobility, and cognitive function.
A recent study from Purdue University, published in Molecular & Cellular Proteomics, explores the role of the nuclear protein Pin1 in regulating this critical cellular process, offering promising insights for future therapeutic interventions.
Longevity.Technology: Senescence has emerged as a key focus in the study of aging and cancer, with implications for the development of senotherapeutics – treatments aimed at modulating the senescence process or even eliminating senescent cells. By understanding the molecular underpinnings of senescence, researchers aim to develop interventions that could either delay the onset of senescence-associated disorders or enhance the clearance of senescent cells, thereby slowing or preventing age-related diseases and extending healthy lifespan.
The study, led by Dr Uma Aryal and his team, leveraged advanced proteomic and phosphoproteomic technologies to explore the complex network of proteins involved in oncogene-induced senescence (OIS). The researchers specifically investigated the role of Pin1, a peptidyl-prolyl cis/trans isomerase, in this process. OIS, triggered by the activation of oncogenes such as Ras, acts as a protective mechanism to halt the proliferation of cells with potential tumorigenic mutations.
The researchers employed a model system using human lung fibroblast cells, which were induced into a senescent state by the activation of the oncogenic Ras variant ER. Observing significant changes in the nuclear proteome and phosphoproteome, the team identified Pin1 as a key regulator of PML nuclear bodies (PML-NBs). PML-NBs are dynamic structures involved in various cellular processes, including tumor suppression and the maintenance of genomic stability. The study revealed that Pin1 interacts with PML proteins, modulating their structure and function through phosphorylation-dependent mechanisms [1].
“Identifying Pin1’s role in oncogene-induced senescence is critical to understanding the mechanisms that drive cells into senescence,” said Rodrigo Mohallem, a PhD candidate involved in the study. “Understanding senescence helps us to understand the aging process and why our bodies become more fragile as we become older. This can lead to more advanced therapeutic strategies to help older people live healthier, more active lives [2].”
The research showed that the depletion of Pin1 led to a reduction in PML-NB formation and a concomitant decrease in markers of senescence – this suggests that Pin1 not only contributes to the establishment of the senescent phenotype but also acts as a tumor suppressor by stabilizing PML-NBs [1].
Further analysis highlighted the phosphorylation of PML at specific sites, which appeared to be regulated by Pin1. These modifications were linked to the recruitment of tumor suppressor proteins into PML-NBs – a process essential for the proper execution of senescence. Notably, the phosphorylation of PML at sites like S518 facilitated Pin1-mediated isomerization, promoting the degradation of certain proteins and preventing their aggregation, which could otherwise lead to cellular dysfunction [1].
The study’s findings illustrate the complexity of OIS, which involves a multitude of proteins and posttranslational modifications (PTMs). These PTMs, including phosphorylation and SUMOylation, play crucial roles in the regulation of key proteins like p53, which is stabilized and activated through interactions with Pin1. The research also suggested that the depletion of Pin1 could lead to an aberrant increase in proteins associated with tumor initiation, such as STAT3 and L1CAM, highlighting the delicate balance Pin1 maintains in regulating cell proliferation and senescence.
The implications of these findings offer potential avenues for therapeutic development. By targeting the regulatory pathways involving Pin1 and PML-NBs, it may be possible to enhance the clearance of senescent cells or prevent their damaging effects on surrounding tissues. Creating more efficient cells that repeatedly recycle proteins, rather than allowing them to aggregate, could translate into a novel therapy for patients with diseases such as Alzheimer’s.
As Dr Aryal noted: “Aging is directly linked to neurological disorders. If we can identify molecular signatures of the aging process, we may be able to figure out biological markers that indicate whether a person is more susceptible to developing Alzheimer’s disease, and we can develop medications and therapies to slow the progression [2].”
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10864342/
[2] https://vet.purdue.edu/news/pvr-s2024-demystifying-the-aging-process.php
